
🔔 Good morning, and welcome to Telda Lens — your daily pulse on Egypt’s markets.
Today: Prime Holding profits soar 160% and El Shams posts growth, while Memphis Pharma eyes a capital hike and Valu launches high-ticket financing.
Market overview
EGX Pulse

🔔 EGX30 ended +0.66% by market close at 51,833 points, the EGX70 rose 0.87% to 12,994 points, and the EGX100 also rose 0.88% to reach 18,133 points
💸 The number of transactions reached 165,337 spread across 1,578,721,025 stocks leading to a turnover of EGP 7.9 billion.
🏷️ Regional investors were the only net sellers.
📈 Top gainers across the broader market Nozha International Hospital (+18.2%), Macro Group Pharmaceuticals (+13.7%), and Mopco (+7.3%).
📉 Top losers: Gogreen for Agricultural Investment (-4.2%), Mohandes Insurance (-3.0%), Creast Mark For Contracting And Real Estate Development (-2.9%.)
⬆️ Top gainers for EGX30 included Orascom Development (+6.0%), TMG Holding (+4.0%), and Rameda (+3.8%).
⬇️ Top losers included: Abu Qir Fertilizers (-1.9%), Telecom Egypt (-1.7%), and Edita (-1.7%).
Other Important Stats:
🧈 24K Gold reached EGP 7,541 per gram, down 1.17% day-on-day but up 6.98% month-on-month.
💲 The USD reached EGP 46.97 at the National Bank of Egypt.
Daily Roundup
Corporate Corner

💰 Prime Holding (PRMH) saw its net profit soar 160% year-on-year in 2025 to EGP 108.44 million, driven by a solid increase in revenues which climbed to EGP 283.2 million from EGP 210 million the previous year, according to its statement to the EGX yesterday. It’s worth noting that the company’s share value rose 27% since the start of 2026, bringing its gains over the past year to 212%.
⬆️ El Shams Housing and Urbanization (ELSH) saw its net profit rise 1.5% year-on-year in 2025 to EGP 162.1 million, supported by revenues that grew to EGP 220.9 million up from EGP 178 million a year earlier, according to its statement to the EGX yesterday. The company’s share value fell 12% since the start of 2026, bringing its gains over the past year to 21%.
In non-earnings news:
💵 Memphis Pharmaceuticals and Chemical Industries (MPCI) has submitted documents to increase its authorized capital from EGP 300 million to EGP 1.1 billion. The submitted documents are currently under review and examination ahead of being presented to the listing committee. The company’s share value is down 2% since the start of 2026, bringing its gains over the past year to 166%.
💸 Fintech company U Consumer Finance (VALU) has rolled out an instant financing service for high-ticket transactions starting at EGP 1 million, allowing users to apply via its app using only their national ID, according to a company statement. The move aims to extend credit access to self-employed and underserved segments who often lack the standard documentation required by traditional banks. It’s worth noting that the company has seen strong momentum in 2026, with its share value up 30% since the start of the year.
Macro view
Egypt in focus

📈 Egypt’s economy grew more than 5.3% in the first half of FY 2025–2026, driven by tourism, manufacturing, and Suez Canal Authority revenues, Planning Minister Ahmed Rostom told Asharq Business. The government targets near-5% growth for the full year, he added. The Central Bank of Egypt sees growth averaging 5.1%, while the International Monetary Fund forecasts 4.7% this fiscal year and 5.4% in 2026–2027.
📝 Egypt’s Finance Ministry has completed a new medium-term debt strategy and submitted it to the Cabinet, a senior government source told EnterpriseAM, aiming to cut borrowing costs and extend maturities. The plan targets lowering debt to below 75% of GDP and interest costs to about 7% within three years by lengthening debt tenors, issuing 15-year local bonds, and boosting liquidity to support re-entry into the JPMorgan Emerging Markets Index.

